Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and lifestyle intervention for breast cancer prevention in high-risk women
2008-006527-30Phase 3Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of metformin in breast cancer (2 arms), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Mar 2009; status: completed.
02
Drugs
metformin
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2008-006527-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006527-30.